CCDS-O Exam Dumps and Practice Questions

In the CMS-HCC model, certain disease groupings are arranged in hierarchies so that when multiple related conditions are reported for the same patient, only the most severe (highest-ranked) HCC in that hierarchy is counted for risk adjustment. This prevents ''double counting'' of clinically related conditions that represent the same underlying burden of illness. The cancer-related HCCs in the 35--38 range are an example of this hierarchical design: if a patient has diagnoses that map to more than one of these HCCs, the model retains the highest-ranked category and suppresses the lower ones. Therefore, the correct hierarchy order is from the most severe category (HCC 35) down sequentially through HCC 36, HCC 37, and HCC 38. From an outpatient CDI perspective, this reinforces why accuracy and specificity matter: documentation should clearly establish the most clinically severe, active, and treated condition so the correct (highest) HCC is captured, rather than relying on nonspecific or less severe descriptors that could under-represent patient complexity.

The documented clinical picture and treatment plan better align with pneumonia than uncomplicated bronchitis, creating a clear documentation/coding consistency opportunity. A LLL infiltrate on chest x-ray is a classic clinical indicator for pneumonia, and prescribing levofloxacin supports treatment of a likely bacterial lower respiratory infection rather than routine viral bronchitis. The patient also has fever, dyspnea, cough, and required an in-office nebulizer treatment, all of which can accompany pneumonia and increase clinical significance. In outpatient CDI practice, the most appropriate query is the one that clarifies the provider's definitive diagnosis when objective findings and management suggest a more specific condition than what is stated (e.g., ''possible bronchitis''). Querying for diabetic complications or heart failure specificity is not as directly supported by the encounter's indicators and treatment actions provided, and ''acuity of bronchitis'' is secondary if the true condition is pneumonia. Clarifying whether pneumonia is present ensures accurate reporting, medical necessity support, and appropriate risk/quality capture.

In outpatient CDI, a prime query opportunity is any diagnosis with unclear ''status'' that materially affects coding, risk adjustment, surveillance, and care planning. ''History of colon cancer'' paired with ''18 months s/p bowel resection'' creates ambiguity: the provider must clarify whether the malignancy is still active (current disease, recurrence, metastasis, ongoing treatment) versus no longer present (history of malignancy, in remission, disease-free status, post-treatment surveillance only). This distinction changes code selection substantially and prevents inappropriate reporting of an active cancer when the encounter is actually follow-up after curative treatment. By contrast, ostomy status is not documented as present, and OSA/COPD ''status'' may be clinically useful but is not inherently ambiguous from the prompt in the same way (they are listed as chronic problems without a conflicting timeline event). ACDIS outpatient CDI practice prioritizes clarifying cancer status because it impacts longitudinal documentation integrity, accurate problem list management, and compliant diagnosis reporting at each visit.

CDI staff do not alter the legal health record and should not ''code it as is'' when documentation is unclear, conflicting, or incomplete in a way that impacts accurate reporting. The compliant next step is to issue a provider query for clarification, ensuring the final record accurately reflects the provider's clinical judgment. ACDIS-guided outpatient CDI emphasizes that queries are a quality and compliance tool: they reconcile discrepancies (e.g., conflicting diagnoses across notes, missing linkage between symptoms and conditions, unclear acuity such as ''CHF'' without type/status, or ambiguous infection documentation). The query should be supported by clinical indicators from the chart and should ask the provider to document the clarified diagnosis/status in the record (progress note, addendum, or appropriate attestation). Escalation to compliance is reserved for patterns of nonresponse, suspected integrity concerns, or systemic issues, not routine discrepancies. The objective is to achieve a complete, consistent clinical story that supports coding, risk adjustment, quality reporting, and medical necessity---through provider clarification, not CDI edits.

For RAF impact in the CMS-HCC model, the most valuable provider education targets are conditions that (1) map to HCCs or interact with HCC hierarchies, and (2) are clearly within the specialist's scope to assess and manage during visits. In this scenario, the endocrinologist is actively treating diabetes and its complications. Diabetes with peripheral neuropathy/vascular disease plus an active non-healing foot ulcer reflects significant diabetic disease burden and often supports additional required coding (e.g., diabetes complication code plus a separate site/severity ulcer code). The history of toe amputations is also important because amputation status can represent ongoing complexity, affects care planning (risk of recurrent ulcer/infection), and may contribute to risk capture depending on the model and associated complications. By contrast, CAD/COPD/HF may not be evaluated by the endocrinologist at the visit, ''A1C'' is a lab value (not a diagnosis), and ''history of prostate cancer'' generally does not risk-adjust like active malignancy. Therefore, educating on documenting diabetes, amputation status, and ulcer details best supports RAF accuracy.